Skip to content
Clinical Trials – home

Regionshospital Nordjylland

Verified siteinfo

Denmark Bispensgade 37, 9800 Hjørring, Denmark

  • 6 trials recruiting
  • Type IIa hyperlipidaemia · Varicella · Acute myocardial infarction
  • Adults and children

About Specializations

Regionshospital Nordjylland in Hjørring, Denmark specialises in clinical trials of conditions such as Type IIa hyperlipidaemia, Varicella, Acute myocardial infarction, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Regionshospital Nordjylland the Department of Anesthesiology and Intensive Care is conducting studies aimed at improving outcomes for patients with cardiovascular conditions. Trials are testing novel agents to lower the risk of death or hospitalization in chronic heart failure and to prevent stroke in people with atrial fibrillation. Research also explores rapid‑response treatments during in‑hospital cardiac arrest to increase survival rates.

  • ASCVD – Atherosclerotic Cardiovascular Disease
  • Chronic Heart Failure With Reduced Ejection Fraction
  • In‑hospital cardiac arrest
  • Prevention of stroke or systemic embolism in atrial fibrillation

With a team of 11 investigators, the site is contributing valuable data to the global effort against heart disease.

Immune System Processes

The department is also active in pediatric infectious‑disease research, focusing on protection against respiratory syncytial virus (RSV). A vaccine‑based study evaluates safety and the ability to prevent medically attended lower respiratory infections in infants.

  • Prevention of RSV in healthy infants

Based in Hjørring, Denmark, the centre collaborates with international partners to accelerate vaccine development.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bispensgade 379800 HjørringDenmark
Recruiting now
6 trials
Conditions studied
20
Partner status
Verified site

More sites in HjørringDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Varicella

Recruiting

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Midtjylland

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Rigshospitalet

Sepsis+1

Recruiting

Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Rigshospitalet

Rheumatoid arthritis

Not yet recruiting

Methotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Abatacept
  • Sponsor:Aalborg University Hospital

Varicella

Not yet recruiting

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Type IIa hyperlipidaemia

Not yet recruiting

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:MK-0616
  • Sponsor:Merck Sharp & Dohme LLC

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.